Global Coalition for Adaptive Research and Polaris Group Ann

Polaris Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial for Patients with GlioblastomaPolaris lead biologic ADI-PEG 20 to be Evaluated Across Multiple International Trial SitesLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA) and Polaris...

Related Keywords

Canada , California , United States , Australia , Howard Chen , Gina Lee , Rachel Rosenstein Sisson , Nicholas Blondin , Polaris Group , National Brain Tumor Society , Asian Fund For Cancer Research , National Foundation For Cancer Research , International Trial Sites , Cure Brain Cancer Foundation , Global Coalition For Adaptive Research , Polaris Pharmaceuticals Inc , Coalition For Adaptive Research , Polaris Now Enrolling , Registrational Phase , Platform Trial , Evaluated Across Multiple International Trial , Global Coalition , Adaptive Research , Polaris Pharmaceuticals , Macarena De La Fuente , Associate Professor , Miami Sylvester Comprehensive Cancer Center , Assistant Professor , Clinical Neurology , Yale School , Principal Investigators , National Foundation , Cancer Research , Asian Fund ,